Last 7 days
0.8%
Last 30 days
31.0%
Last 90 days
-4.3%
Trailing 12 Months
62.2%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 19.4B | 19.9B | 20.2B | 0 |
2022 | 19.4B | 19.1B | 19.0B | 19.2B |
2021 | 17.9B | 19.2B | 19.5B | 19.5B |
2020 | 18.5B | 17.5B | 17.5B | 17.6B |
2019 | 18.2B | 18.2B | 18.3B | 18.5B |
2018 | 20.1B | 19.4B | 19.0B | 18.3B |
2017 | 20.8B | 20.8B | 20.5B | 20.6B |
2016 | 20.7B | 21.1B | 21.3B | 21.1B |
2015 | 18.4B | 18.9B | 19.5B | 20.1B |
2014 | 13.8B | 15.5B | 17.3B | 17.9B |
2013 | 10.0B | 10.2B | 10.4B | 12.1B |
2012 | 9.4B | 9.6B | 9.7B | 9.9B |
2011 | 9.1B | 9.1B | 9.1B | 9.4B |
2010 | 8.9B | 8.9B | 8.9B | 9.0B |
2009 | 0 | 8.9B | 9.0B | 8.8B |
2008 | 0 | 0 | 0 | 8.6B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 22, 2023 | fisher richard w | sold | -68,220 | 68.22 | -1,000 | - |
Nov 21, 2023 | fisher richard w | sold | -331,650 | 66.33 | -5,000 | - |
Aug 09, 2023 | blunt roy | acquired | - | - | 2,798 | - |
Jun 02, 2023 | arbour paola m | acquired | 1,212,950 | 31.4595 | 38,556 | evp, chief information officer |
Jun 02, 2023 | arbour paola m | sold | -2,900,340 | 75.224 | -38,556 | evp, chief information officer |
May 26, 2023 | rusckowski stephen h | acquired | - | - | 2,846 | - |
May 26, 2023 | rusckowski stephen h | acquired | - | - | 3,682 | - |
May 26, 2023 | fitzgerald meghan | acquired | - | - | 2,846 | - |
May 26, 2023 | bierman james l | acquired | - | - | 2,846 | - |
May 26, 2023 | haney cecil d | acquired | - | - | 3,682 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 07, 2023 | Hudson Bay Capital Management LP | added | 134 | 4,847,470 | 10,231,000 | 0.04% |
Dec 06, 2023 | CITIGROUP INC | reduced | -19.46 | -17,874,500 | 33,509,000 | 0.03% |
Dec 01, 2023 | B. Riley Wealth Advisors, Inc. | reduced | -2.93 | -74,424 | 273,312 | 0.01% |
Nov 30, 2023 | Neo Ivy Capital Management | new | - | 155,000 | 155,000 | 0.07% |
Nov 27, 2023 | USA FINANCIAL FORMULAS | new | - | 91,719 | 91,719 | 0.14% |
Nov 27, 2023 | BANQUE PICTET & CIE SA | reduced | -4.51 | -1,404,560 | 4,787,570 | 0.06% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -2.3 | -639,151 | 2,419,680 | -% |
Nov 22, 2023 | KBC Group NV | unchanged | - | - | 21,000 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | added | 280 | 1,919,350 | 2,842,030 | 0.07% |
Nov 22, 2023 | Polar Capital Holdings Plc | added | 211 | 13,385,100 | 22,165,600 | 0.16% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Mar 08, 2023 | blackrock inc. | 11.2% | 11,498,067 | SC 13G/A | |
Feb 14, 2023 | harris associates l p | 5.1% | 5,463,374 | SC 13G/A | |
Feb 14, 2023 | glenview capital management, llc | 8.23% | 8,896,111 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.45% | 11,304,003 | SC 13G/A | |
Feb 08, 2023 | invesco ltd. | 3.9% | 4,176,487 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.4% | 10,147,574 | SC 13G | |
Feb 14, 2022 | glenview capital management, llc | 6.84% | 7,327,108 | SC 13G/A | |
Feb 14, 2022 | invesco ltd. | 5.2% | 5,553,758 | SC 13G | |
Feb 11, 2022 | harris associates l p | 5.6% | 6,000,495 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 10.13% | 10,855,165 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 24, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 21, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 17, 2023 | 8-K | Current Report | |
Oct 30, 2023 | 8-K | Current Report | |
Oct 30, 2023 | 10-Q | Quarterly Report | |
Sep 08, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 508.7B | 360.0B | 2.46% | 0.72% | 23.46 | 1.41 | 14.24% | 11.62% |
CVS | 96.7B | 347.8B | 9.25% | -26.74% | 11.1 | 0.28 | 10.34% | 159.11% |
CI | 91.1B | 189.9B | -12.37% | -22.06% | 13.64 | 1.92 | 5.24% | 22.27% |
HCA | 69.2B | 63.2B | 11.16% | 6.57% | 12.11 | 1.1 | 5.62% | 6.32% |
CNC | 39.4B | 150.1B | 4.91% | -14.72% | 16.13 | 0.26 | 6.04% | 21.35% |
MID-CAP | ||||||||
DVA | 9.8B | 11.9B | 26.82% | 43.59% | 16.13 | 0.82 | 2.36% | -10.41% |
UHS | 9.6B | 14.0B | 6.07% | 6.08% | 14.25 | 0.69 | 6.03% | -8.61% |
CHE | 8.6B | 2.2B | -1.60% | 9.83% | 35.34 | 3.88 | 4.50% | -6.69% |
ACHC | 6.7B | 2.9B | -0.53% | -12.01% | -365.93 | 2.34 | 13.16% | -106.47% |
AMN | 2.6B | 4.1B | 13.56% | -40.93% | 9.25 | 0.63 | -25.26% | -41.25% |
SMALL-CAP | ||||||||
AMEH | 1.6B | 1.3B | 4.12% | 12.39% | 34.86 | 1.17 | 27.06% | -27.04% |
ADUS | 1.5B | 1.0B | 10.48% | -13.37% | 25.78 | 1.44 | 10.84% | 30.19% |
BKD | 1.0B | 3.0B | 22.30% | 77.33% | -8.11 | 0.34 | 6.98% | 58.07% |
BEAT | 35.8M | - | 8.80% | -76.75% | -2.47 | - | - | -27.68% |
AMS | 15.8M | 20.7M | 12.00% | -11.27% | 54.39 | 0.76 | 6.53% | -78.75% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -0.3% | 5,066 | 5,082 | 5,021 | 4,990 | 4,801 | 4,638 | 4,745 | 4,856 | 4,894 | 4,954 | 4,781 | 4,915 | 4,557 | 3,648 | 4,520 | 4,806 | 4,568 | 4,560 | 4,545 | 4,619 | 4,489 |
EBITDA Margin | -1.8% | 0.16* | 0.16* | 0.16* | 0.16* | 0.17* | 0.19* | 0.19* | 0.19* | 0.20* | 0.15* | 0.15* | 0.14* | 0.12* | 0.13* | 0.12* | - | - | - | - | - | - |
Interest Expenses | 0.4% | 227 | 226 | 221 | 219 | 222 | 222 | 227 | 221 | 227 | 235 | 240 | 242 | 263 | 255 | 243 | 243 | 244 | 247 | 251 | 246 | 249 |
Income Taxes | -1.2% | 79.00 | 80.00 | 84.00 | 47.00 | 112 | 86.00 | 99.00 | 108 | 197 | 61.00 | 45.00 | 130 | -197 | 45.00 | -75.00 | 85.00 | 22.00 | 33.00 | 20.00 | 53.00 | 6.00 |
Earnings Before Taxes | -7.5% | 345 | 373 | 380 | 321 | 380 | 265 | 378 | 528 | 774 | 319 | 267 | 676 | -304 | 214 | 85.00 | 209 | -125 | 152 | 84.00 | 148 | 71.00 |
EBT Margin | -3.7% | 0.07* | 0.07* | 0.07* | 0.07* | 0.08* | 0.10* | 0.10* | 0.10* | 0.10* | 0.05* | 0.05* | 0.04* | 0.01* | 0.02* | 0.02* | - | - | - | - | - | - |
Net Income | -9.2% | 266 | 293 | 296 | 274 | 268 | 179 | 280 | 419 | 578 | 257 | 222 | 546 | -106 | 169 | 159 | 124 | -146 | 121 | 72.00 | 102 | 65.00 |
Net Income Margin | -1.5% | 0.06* | 0.06* | 0.05* | 0.05* | 0.06* | 0.08* | 0.08* | 0.08* | 0.08* | 0.05* | 0.05* | 0.04* | 0.02* | 0.02* | 0.01* | - | - | - | - | - | - |
Free Cashflow | -29.8% | 327 | 466 | 214 | 131 | 150 | -33.00 | 73.00 | 53.00 | 321 | 123 | 413 | 280 | 507 | 2,133 | -53.00 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 1.6% | 27,590 | 27,157 | 27,067 | 27,156 | 27,076 | 26,621 | 26,650 | 27,579 | 25,913 | 26,565 | 27,579 | 27,106 | 26,187 | 26,250 | 23,823 | 23,365 | 23,357 | 23,207 | 23,158 | 22,430 | 22,265 |
Current Assets | 6.1% | 6,359 | 5,995 | 5,869 | 5,981 | 5,998 | 6,064 | 6,128 | 7,075 | 6,905 | 7,417 | 6,699 | 7,147 | 7,808 | 7,947 | 5,388 | 5,081 | 4,789 | 4,704 | 4,582 | 4,636 | 4,492 |
Cash Equivalents | 12.8% | 1,054 | 934 | 766 | 858 | 1,208 | 1,351 | 1,405 | 2,364 | 2,292 | 2,194 | 2,141 | 2,446 | 3,300 | 3,514 | 613 | 262 | 314 | 249 | 252 | 411 | 500 |
Inventory | 2.2% | 413 | 404 | 407 | 405 | 394 | 387 | 391 | 384 | 376 | 364 | 368 | 368 | 349 | 337 | 324 | 310 | 311 | 309 | 308 | 305 | 307 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,001 | 6,995 | 6,996 | 6,993 | 6,888 |
Goodwill | 0.6% | 10,415 | 10,350 | 10,258 | 10,123 | 707 | 206 | 84.00 | 9,261 | 65.00 | 76.00 | 25.00 | 1,581 | 78.00 | 76.00 | 83.00 | 43.00 | 34.00 | 18.00 | 3.00 | 220 | 211 |
Liabilities | 1.1% | 22,409 | 22,156 | 22,262 | 22,548 | 22,501 | 22,510 | 22,236 | 23,322 | 22,230 | 23,362 | 23,546 | 24,217 | 24,186 | 24,056 | 21,794 | 21,422 | 21,393 | 21,028 | 21,045 | 20,302 | 20,163 |
Current Liabilities | 6.7% | 4,432 | 4,152 | 4,219 | 4,476 | 4,276 | 4,368 | 4,668 | 5,109 | 5,379 | 5,071 | 4,930 | 4,847 | 5,843 | 5,585 | 4,095 | 4,205 | 3,928 | 4,150 | 3,725 | 3,857 | 4,224 |
Long Term Debt | 0.0% | 14,901 | 14,907 | 14,935 | 14,934 | 14,962 | 14,947 | 14,719 | 15,511 | 14,009 | 15,091 | 15,098 | 15,574 | 15,561 | 15,728 | 15,082 | 14,580 | 14,858 | 14,312 | 14,814 | 14,644 | 14,178 |
Shareholder's Equity | -46.3% | 1,464 | 2,724 | 2,580 | 1,142 | 2,507 | 2,114 | 2,056 | 2,054 | 1,635 | 1,169 | 1,016 | 937 | 522 | 633 | 503 | 437 | 448 | 670 | 618 | 624 | 658 |
Retained Earnings | 18.8% | -436 | -537 | -660 | -803 | -905 | -1,036 | -1,074 | -1,214 | -1,463 | -1,912 | -2,031 | -2,128 | -2,542 | -2,346 | -2,434 | -2,513 | -2,469 | -2,237 | -2,254 | -2,236 | -2,231 |
Additional Paid-In Capital | 0.4% | 4,818 | 4,800 | 4,774 | 4,778 | 4,771 | 4,756 | 4,765 | 4,877 | 4,862 | 4,854 | 4,841 | 4,844 | 4,826 | 4,751 | 4,739 | 4,760 | 4,751 | 4,755 | 4,748 | 4,747 | 4,733 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,645 | 5,526 | 5,382 | 5,221 | 5,169 |
Shares Outstanding | -0.2% | 102 | 102 | 102 | - | 108 | 108 | 107 | - | 107 | 107 | 106 | - | 105 | 105 | 104 | - | 104 | 103 | 103 | - | 102 |
Minority Interest | 2.4% | 1,414 | 1,381 | 1,347 | 1,317 | 1,272 | 1,027 | 1,000 | 1,026 | 913 | 908 | 893 | 909 | 896 | 890 | 861 | 854 | 830 | 825 | 808 | 806 | 766 |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -15.9% | 503,000,000 | 598,000,000 | 449,000,000 | 421,000,000 | 315,000,000 | 119,000,000 | 228,000,000 | 357,000,000 | 432,000,000 | 245,000,000 | 534,000,000 | 446,000,000 | 593,000,000 | 2,239,000,000 | 129,000,000 | 520,000,000 | 419,000,000 | 284,000,000 | 10,000,000 | 250,000,000 | 338,000,000 |
Share Based Compensation | -21.1% | 15,000,000 | 19,000,000 | 14,000,000 | 9,000,000 | 13,000,000 | 18,000,000 | 16,000,000 | 13,000,000 | 13,000,000 | 16,000,000 | 14,000,000 | 6,000,000 | 11,000,000 | 14,000,000 | 13,000,000 | 8,000,000 | 11,000,000 | 12,000,000 | 11,000,000 | 12,000,000 | 14,000,000 |
Cashflow From Investing | 6.6% | -169,000,000 | -181,000,000 | -286,000,000 | -306,000,000 | -302,000,000 | -140,000,000 | -60,000,000 | -1,516,000,000 | 997,000,000 | -50,000,000 | -145,000,000 | -1,202,000,000 | -117,000,000 | -85,000,000 | -204,000,000 | -193,000,000 | -123,000,000 | -164,000,000 | -139,000,000 | -235,000,000 | -105,000,000 |
Cashflow From Financing | 14.1% | -214,000,000 | -249,000,000 | -255,000,000 | -465,000,000 | -156,000,000 | -33,000,000 | -1,127,000,000 | 1,231,000,000 | -1,331,000,000 | -142,000,000 | -694,000,000 | -98,000,000 | -690,000,000 | 747,000,000 | 426,000,000 | -379,000,000 | -231,000,000 | -123,000,000 | -30,000,000 | -104,000,000 | -136,000,000 |
Buy Backs | -100.0% | - | 40,000,000 | 50,000,000 | 250,000,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net operating revenues | $ 5,066 | $ 4,801 | $ 15,169 | $ 14,184 |
Grant income | 3 | 54 | 14 | 154 |
Equity in earnings of unconsolidated affiliates | 51 | 51 | 155 | 151 |
Operating expenses: | ||||
Salaries, wages and benefits | 2,288 | 2,230 | 6,831 | 6,538 |
Supplies | 877 | 817 | 2,659 | 2,413 |
Other operating expenses, net | 1,101 | 1,018 | 3,319 | 2,966 |
Depreciation and amortization | 224 | 209 | 654 | 628 |
Impairment and restructuring charges, and acquisition-related costs | 47 | 24 | 84 | 97 |
Litigation and investigation costs | 14 | 12 | 28 | 50 |
Net losses (gains) on sales, consolidation and deconsolidation of facilities | 1 | 0 | (12) | 0 |
Operating income | 568 | 596 | 1,775 | 1,797 |
Interest expense | (227) | (222) | (674) | (671) |
Other non-operating income, net | 4 | 6 | 8 | 6 |
Loss from early extinguishment of debt | 0 | 0 | (11) | (109) |
Income from continuing operations, before income taxes | 345 | 380 | 1,098 | 1,023 |
Income tax expense | (79) | (112) | (243) | (297) |
Income from continuing operations, before discontinued operations | 266 | 268 | 855 | 726 |
Income from discontinued operations, net of tax | 0 | 0 | 0 | 1 |
Net income | 266 | 268 | 855 | 727 |
Less: Net income available to noncontrolling interests | 165 | 137 | 488 | 418 |
Net income available to Tenet Healthcare Corporation common shareholders | 101 | 131 | 367 | 309 |
Amounts available to Tenet Healthcare Corporation common shareholders: | ||||
Income from continuing operations, net of tax | 101 | 131 | 367 | 308 |
Income from discontinued operations, net of tax | 0 | 0 | 0 | 1 |
Net income available to Tenet Healthcare Corporation common shareholders | $ 101 | $ 131 | $ 367 | $ 309 |
Basic | ||||
Continuing operations (in dollars per share) | $ 0.99 | $ 1.21 | $ 3.60 | $ 2.86 |
Discontinued operations (in dollars per share) | 0 | 0 | 0 | 0.01 |
Total earnings per share, basic (in dollars per share) | 0.99 | 1.21 | 3.60 | 2.87 |
Diluted | ||||
Continuing operations (in dollars per share) | 0.94 | 1.16 | 3.41 | 2.81 |
Discontinued operations (in dollars per share) | 0 | 0 | 0 | 0.01 |
Total earnings per share, diluted (in dollars per share) | $ 0.94 | $ 1.16 | $ 3.41 | $ 2.82 |
Weighted average shares and dilutive securities outstanding (in thousands): | ||||
Basic (in shares) | 101,544 | 107,923 | 101,869 | 107,732 |
Diluted (in shares) | 104,425 | 109,888 | 105,021 | 112,288 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,054 | $ 858 |
Accounts receivable | 2,897 | 2,943 |
Inventories of supplies, at cost | 413 | 405 |
Assets held for sale | 140 | 0 |
Other current assets | 1,855 | 1,775 |
Total current assets | 6,359 | 5,981 |
Investments and other assets | 3,152 | 3,147 |
Deferred income taxes | 4 | 19 |
Property and equipment, at cost, less accumulated depreciation and amortization ($6,462 at September 30, 2023 and $6,201 at December 31, 2022) | 6,260 | 6,462 |
Goodwill | 10,415 | 10,123 |
Other intangible assets, at cost, less accumulated amortization ($1,463 at September 30, 2023 and $1,428 at December 31, 2022) | 1,400 | 1,424 |
Total assets | 27,590 | 27,156 |
Current liabilities: | ||
Current portion of long-term debt | 141 | 145 |
Accounts payable | 1,202 | 1,504 |
Accrued compensation and benefits | 787 | 778 |
Professional and general liability reserves | 264 | 255 |
Accrued interest payable | 273 | 213 |
Liabilities held for sale | 17 | 0 |
Contract liabilities | 86 | 110 |
Other current liabilities | 1,662 | 1,471 |
Total current liabilities | 4,432 | 4,476 |
Long-term debt, net of current portion | 14,901 | 14,934 |
Professional and general liability reserves | 787 | 790 |
Defined benefit plan obligations | 327 | 331 |
Deferred income taxes | 278 | 217 |
Other long-term liabilities | 1,684 | 1,800 |
Total liabilities | 22,409 | 22,548 |
Commitments and contingencies | ||
Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,303 | 2,149 |
Shareholders’ equity: | ||
Common stock, $0.05 par value; authorized 262,500 shares; 157,247 shares issued at September 30, 2023 and 156,462 shares issued at December 31, 2022 | 8 | 8 |
Additional paid-in capital | 4,818 | 4,778 |
Accumulated other comprehensive loss | (176) | (181) |
Accumulated deficit | (436) | (803) |
Common stock in treasury, at cost, 55,695 shares at September 30, 2023 and 54,216 shares at December 31, 2022 | (2,750) | (2,660) |
Total shareholders’ equity | 1,464 | 1,142 |
Noncontrolling interests | 1,414 | 1,317 |
Total equity | 2,878 | 2,459 |
Total liabilities and equity | $ 27,590 | $ 27,156 |
 CEO | Dr. Saumya Sutaria M.D. |
---|---|
 WEBSITE | www.tenethealth.com |
 EMPLOYEES | 65535 |